Literature DB >> 24273892

Celastrus orbiculatus Thunb. ameliorates high-fat diet-induced non-alcoholic fatty liver disease in guinea pigs.

Ying Zhang1, Yanhong Si, Lei Zhai, Nana Yang, Shutong Yao, Hui Sang, Dandan Zu, Xin Xu, Shucun Qin, Jianhua Wang.   

Abstract

Celastrus orbiculatus Thunb. (COT) is a traditional Chinese herb. In this study, an experiment was designed to investigate the potential protective effect of COT on the development of non-alcoholic fatty liver disease (NAFLD) induced by high fat diet and to explore the underlying mechanisms. We established a guinea pig model of NAFLD and treated the animals with three doses of COT or 20 mg/kg/d simvastatin (a positive control drug) for 8 weeks. H&E staining of liver tissue sections indicated that COT remarkably improved histopathological change of liver induced by high fat diet. Serum biochemical assays revealed that COT significantly decreased ALT and AST activities in serum. Besides, COT also reduced body weight and liver weight of guinea pigs under high fat diet. Hepatic lipid analysis showed that COT remarkably decreased the contents of total cholesterol (TC), free cholesterol (FC), cholesterol ester (CE) and triglyceride (TG) in liver of guinea pigs fed high fat diet in a dose-dependent manner. The analysis of hepatic genes involved in cholesterol metabolism by quantitative real-time PCR revealed that COT upregulated the mRNA abundance of cholesterol 7alpha-hydroxylase A1 (CYP7A1) and 3-hydroxy-3-methyl-glutaryl-CoA reductase (HMGCR). Measurement of biochemical parameters in liver indicated that COT attenuated oxidative stress and lowered NO and iNOS levels in guinea pigs under high fat diet. These results reveal that administration of COT effectively ameliorates high-fat diet-induced NAFLD in guinea pigs through decreasing hepatic lipid levels, suppressing oxidative stress and lowering NO and iNOS levels in liver.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24273892

Source DB:  PubMed          Journal:  Pharmazie        ISSN: 0031-7144            Impact factor:   1.267


  5 in total

Review 1.  Herbal Medicine in the Treatment of Non-Alcoholic Fatty Liver Diseases-Efficacy, Action Mechanism, and Clinical Application.

Authors:  Yu Xu; Wei Guo; Cheng Zhang; Feiyu Chen; Hor Yue Tan; Sha Li; Ning Wang; Yibin Feng
Journal:  Front Pharmacol       Date:  2020-05-12       Impact factor: 5.810

2.  Isolation and identification of Streptococcus suis from sick pigs in Bali, Indonesia.

Authors:  I Nengah Kerta Besung; I Gusti Ketut Suarjana; Kadek Karang Agustina; Ida Bagus Oka Winaya; Hamong Soeharsono; Ni Ketut Suwiti; Gusti Ngurah Mahardika
Journal:  BMC Res Notes       Date:  2019-12-05

3.  Comprehensive metabolomics analysis based on UPLC-Q/TOF-MSE and the anti-COPD effect of different parts of Celastrus orbiculatus Thunb.

Authors:  Na Yang; Han Wang; Hongqiang Lin; Junli Liu; Baisong Zhou; Xiaoling Chen; Cuizhu Wang; Jinping Liu; Pingya Li
Journal:  RSC Adv       Date:  2020-02-26       Impact factor: 4.036

4.  High-fat but not sucrose intake is essential for induction of dyslipidemia and non-alcoholic steatohepatitis in guinea pigs.

Authors:  David Højland Ipsen; Pernille Tveden-Nyborg; Bidda Rolin; Günaj Rakipovski; Maria Beck; Line Winther Mortensen; Lasse Færk; Peter Mikael Helweg Heegaard; Peter Møller; Jens Lykkesfeldt
Journal:  Nutr Metab (Lond)       Date:  2016-08-09       Impact factor: 4.169

Review 5.  The Impacts of Herbal Medicines and Natural Products on Regulating the Hepatic Lipid Metabolism.

Authors:  Sha Li; Yu Xu; Wei Guo; Feiyu Chen; Cheng Zhang; Hor Yue Tan; Ning Wang; Yibin Feng
Journal:  Front Pharmacol       Date:  2020-03-24       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.